Cited by 89Peripheral Artery Disease ManagementLipoproteins and Cardiovascular HealthDiabetic Foot Ulcer Assessment and Management

Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease

Open access
Hsu, Chien-Yi, Chen, Yung-Tai, Su, Yu-Wen, Chang, Chun-Chin, Huang, Po-Hsun, Lin, Shing-Jong·2017·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Although there is evidence to support the beneficial effects of statins on major cardiovascular events, few studies address the protective effect of statins on limb outcome. Objective: To investigate whether the use of statin is associated with a risk reduction in lower-extremity amputation in type 2 diabetes mellitus (DM) patients with peripheral arterial disease (PAD). Design: Observational cohort study. Setting: A nationwide DM database in Taiwan from 2000 to 2011. Patients: A total of 69,332 patients aged ≥20 years with DM and PAD were identified. Intervention: Patients were divided into three groups: 11,409 patients were statin users, 4430 patients used nonstatin lipid-lowering agents, and 53,493 patients were nonusers. Main Outcome Measures: The primary outcome was lower-extremity amputation. Secondary outcomes were in-hospital cardiovascular death and all-cause mortality. Results: Compared with nonusers, statin users were associated with lower risks of lower-extremity amputation [adjusted hazard ration (aHR), 0.75; 95% confidence interval (CI), 0.62 to 0.90], in-hospital cardiovascular death (aHR, 0.78; 95% CI, 0.69 to 0.87), and all-cause mortality (aHR, 0.73; 95% CI, 0.69 to 0.77). In the propensity score matching analysis, the effect of statin on the risk of lower-extremity amputation was consistent. Only statin users were associated with the risk reduction of lower-extremities amputation (HR, 0.77; 95% CI, 0.61 to 0.97) and cardiovascular death (HR, 0.78; 95% CI, 0.68 to 0.89) when taking competing risk of death into consideration. Conclusions: Compared with statin nonusers who were never treated with lipid-lowering drugs, this study found that statin users had a lower risk of lower-extremity amputation and cardiovascular death in patients with DM and PAD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-3717

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several observational studies have shown that statins reduce the rate of amputation with relative risk reductions between 18% and 35% that are not seen with the use of nonstatin lipid-lowering therapies.

    “Several observational studies have shown that statins reduce the rate of amputation with relative risk reductions between 18% and 35% that are not seen with the use of nonstatin lipid-lowering therapies such as fibrates, bile acid sequestrants, nicotinic acid, and cholesterol absorption inhibitors.67,68”

    From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [67]

    The Results report a 25% lower risk of any lower-extremity amputation among statin users, without a significant reduction among nonstatin users. The Discussion reports a 35% reduction in another observational study, but its 18% figure is for a composite of limb outcomes, including revascularization and ischemic amputation—not amputation alone. The cited paper therefore does not establish the full 18%–35% range specifically for amputation. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hsu, C.-Y., Chen, Y.-T., Su, Y.-W., Chang, C.-C., Huang, P.-H., & Lin, S.-J.
Affiliations
  • Taipei Medical University Hospital (TW)
  • Taipei Municipal YangMing Hospital (TW)
  • Taipei Veterans General Hospital (TW)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-04-07
Volume
102
Issue
7
Pages
2373-2381
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2604850438
Cited by
89
References
32
Citations by year
2026: 4 · 2025: 11 · 2024: 8 · 2023: 8 · 2022: 15 · 2021: 8 · 2020: 16 · 2019: 12 · 2018: 6 · 2017: 1
FWCI
9.80
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Health and Welfare (MOHW104‐TDU‐B‐211‐113‐003)
  • Taipei Veterans General Hospital
Topics
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords
statins, lower limb amputation, type 2 diabetes, peripheral arterial disease, cardiovascular mortality, all-cause mortality, lipid-lowering drugs, limb salvage, competing risk of death
MeSH terms
Aged, Amputation, Surgical, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Taiwan, Cohort Studies, Comorbidity, Incidence, Confidence Intervals, Survival Analysis, Databases, Factual, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lower Extremity, Risk Reduction Behavior, Propensity Score, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review